Just a quick note that the narrative in this Citizen's Petition rejection related to Vitrase (ovine hyaluronidase) from ISTA Pharmaceuticals is also helpful in assessing the chances that Amarin $AMRN will receive New Chemical Entity (NCE) status from the FDA for its triglycerides lowering product. Previously, I posted an extensive review of the subject here on the Biotech Due Diligence blog.